Welcome to the Settlement Website for the Reata Securities Litigation.

The Court-appointed Lead Plaintiff, UMC Benefit Board, Inc., US Equity Fund-P Series, a series of the Wespath Funds Trust, US Equity Index Fund-P Series, a series of the Wespath Funds Trust, Wespath Institutional Investments LLC, US Equity Fund-I Series, a series of Wespath Funds Trust, and US Equity Index Fund-I Series, a series of the Wespath Funds Trust (“Wespath” or “Lead Plaintiff”), on behalf of itself and the Settlement Class (defined below), has reached a proposed settlement with defendant Reata Pharmaceuticals, Inc. (“Reata” or the “Company”), the Individual Defendants (as defined in the Stipulation of Settlement (“Stipulation”)), and the Underwriter Defendants (as defined in the Stipulation) (collectively the “Defendants”) for $45,000,000 in cash that, if approved, will resolve all claims in the Action (the “Settlement”).

If you are a member of the Settlement Class, your rights will be affected, and you may be eligible for a payment from the Settlement. The Settlement Class consists of:

All persons or entities who purchased or otherwise acquired the publicly traded common stock of Reata between November 14, 2016 and December 8, 2021, inclusive (the “Settlement Class Period”), including all persons or entities who purchased or otherwise acquired Reata common stock pursuant and/or traceable to Reata’s 2019 Offering and/or 2020 Offering (the “Offerings Subclass”).

If you are a member of the Settlement Class, to be potentially eligible to receive a payment under the proposed Settlement, you must submit a Claim Form no later than April 24, 2024. Payments to Authorized Claimants will be made only if the Court approves the Settlement and the Plan of Allocation, and only after any appeals are resolved, and after the completion of all claims processing. Please be patient, as this process will take some time to complete.

Please read the Notice to fully understand your rights and options. The Frequently Asked Questions page of this website has more information on your rights as a member of the Settlement Class.


Your Legal Rights and Options in This Action
Submit a Claim Form

To be eligible to receive a payment from the Settlement Fund, a Settlement Class Member must submit a Claim Form online, via email, or by first-class mail postmarked no later than April 24, 2024.

Objection

Any objections to the proposed Settlement, the proposed Plan of Allocation, or the request for attorneys’ fees and reimbursement of Litigation Expenses must be received on or before March 8, 2024, in accordance with the instructions contained in the Notice.

Exclude Yourself

Any requests for exclusion from the Settlement Class must be received on or before March 8, 2024, in accordance with the instructions contained in the Notice. If you exclude yourself from the Settlement Class, you will not be eligible to receive any payment from the Settlement Fund. This is the only option that allows you ever to be part of any other lawsuit against any of the Defendants’ Releasees concerning the Released Plaintiffs’ Claims.

Attend the Settlement Hearing

Filing a written objection and notice of intention to appear by March 8, 2024 allows you to speak in Court, at the discretion of the Court, about the fairness of the proposed Settlement, the Plan of Allocation, and/or the request for attorneys’ fees and reimbursement of Litigation Expenses. If you submit a written objection, you may (but you do not have to) attend the hearing and, at the discretion of the Court, speak to the Court about your objection. The Settlement Hearing is currently scheduled for March 29, 2024 at 9:00 a.m.

Do Nothing

If you are a member of the Settlement Class and you do not submit a valid Claim Form, you will not be eligible to receive any payment from the Settlement Fund. You will, however, remain a member of the Settlement Class, which means that you give up your right to sue about the claims that are resolved by the Settlement, and you will be bound by any judgments or orders entered by the Court in the Action.